The Impact of Article 39.3 in India: A Practical Perspective
India is currently debating whether to provide exclusivity for pharmaceutical test data. The various Ministries in the Government are planning to meet on 12 July 2006. I-MAK has produced a document which reviews the practical impact of the current proposals and provides recommendations which should be considered before a final decision is reached.
posted by Tahir at
3:12 pm
|
1 comments
